まとめ
腫瘍促進剤であるホルボルミリスタートアセテート (PMA) は,皮膚細胞のβ受容体をアデニラートサイクラゼから切り離します. この解離は,ベースレベルや受容体数に影響を与えることなく,周期的なAMP生成を抑制します.
科学分野:
- バイオケミストリー バイオケミストリー
- 細胞生物学 細胞生物学
- 皮膚科 皮膚科について
背景:
- 変異した細胞や腫瘍は,ベータアドレナージック受容体の機能が変化し,アデニラートサイクラースの反応性が変化している.
- Phorbol myristate acetate (PMA) は,マウスの皮膚における強力な腫瘍促進剤である.
- PMAは,カテキオラミンに対する表皮反応の有意な損失をインビオで誘導する.
研究 の 目的:
- PMAがカテキオラミンに対する表皮反応を抑制するメカニズムを調査する.
- PMAがベータアドレネルゲン受容体数,アフェニティ,またはアデニル酸サイクラゼとの結合に影響するかどうかを判断する.
主な方法:
- マウスの皮膚をPhorbol myristate acetate (PMA) で治療する.
- カテコアミン (例えば,イソプレナリン) に対する表皮反応の評価.
- ベース値と刺激されたサイクルAMP値の測定.
- ベータアドレナゲン受容体数と親和度の評価.
主要な成果:
- PMA治療は基礎周期性AMPレベルを変化させなかった.
- PMA治療は,表皮ベータ受容体の数や親和性を変化させなかった.
- PMAは,イソプレナリン注射に対する反応として,循環型AMPの蓄積を急激に抑制しました.
- 証拠によると,PMAはアデニル酸サイクラゼから表皮ベータ受容体を分離する.
結論:
- PMAによるカテキオラミンに対する表皮反応の阻害は,β-アドレナリン受容体をアデニラートサイクラゼから切り離すことによって媒介されます.
- この解離は,基礎周期性AMPレベルや受容体結合特性の変化とは無関係に起こる.
さらに関連する動画
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
関連する概念動画
Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
Cadherins in Tissue Organization
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
